Alto Neuroscience stock rises as firm secures $120M to advance depression drug

2026-3-17 15:37

Alto's funding boost for depression drug trials could accelerate innovative treatments, potentially transforming neuropsychiatric care landscapes. The post Alto Neuroscience stock rises as firm secures $120M to advance depression drug appeared first on Crypto Briefing. origin »

Bitcoin price in Telegram @btc_price_every_hour

FlashX Advance (FSXA) на Currencies.ru

$ 0 (+0.00%)
Объем 24H $0
Изменеия 24h: 0.00 %, 7d: 0.00 %
Cегодня L: $0 - H: $0
Капитализация $0 Rank 99999
Доступно / Всего 0 FSXA

alto drug depression stock rises neuroscience advance